INVESTABOT
Equity Research
XNYS · PHARMACEUTICAL PREPARATIONS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-08-17. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-08-10. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-08-07. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-07-07. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-06-26. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-06-10. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-05-28. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-05-22. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-05-20. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
Eli Lilly & (LLY) had 1 Form 144 pre-sale notice filed on 2026-05-06. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 3 unique sellers · Institutional activity: not available - insufficient comparable institutions for the latest complete quarter.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| September 21, 2026 | Alvarez Ralph | — | GRANT | 10.66 | $1,165 | ~$12K |
| September 21, 2026 | Fyrwald J Erik | — | GRANT | 8.51 | $1,165 | ~$10K |
| September 21, 2026 | Luciano Juan R | — | GRANT | 13.66 | $1,165 | ~$16K |
| September 21, 2026 | Sulzberger Gabrielle | — | GRANT | 4.26 | $1,165 | ~$5K |
| September 9, 2026 | Seymour Melissa | EVP, Global Quality | GIFT | -12 | — | — |
| September 2, 2026 | Hernandez Edgardo | EVP & Pres., Mfg. Operations | GIFT | -13 | — | — |
| September 2, 2026 | Dozier Eric | EVP, Chief People Officer | GIFT | -216 | — | — |
| August 17, 2026 | Sulzberger Gabrielle | — | GRANT | 4.19 | $1,183 | ~$5K |
| August 17, 2026 | Luciano Juan R | — | GRANT | 13.45 | $1,183 | ~$16K |
| August 17, 2026 | Fyrwald J Erik | — | GRANT | 8.38 | $1,183 | ~$10K |
| August 17, 2026 | Alvarez Ralph | — | GRANT | 10.49 | $1,183 | ~$12K |
| August 17, 2026 | Jonsson Patrik | EVP & President, LLY Int'l | SELL | -6,500 | $1,175 | ~$7.6M |
| August 10, 2026 | Zakrowski Donald A | SVP, Finance, & CAO | SELL | -2,000 | $1,185 | ~$2.4M |
| August 7, 2026 | Hakim Anat | EVP, GC & Secretary | SELL | -5,000 | $1,190 | ~$6.0M |
| August 1, 2026 | Seymour Melissa | EVP, Global Quality | OPTION_EXERCISE | 981 | — | — |
| August 1, 2026 | Seymour Melissa | EVP, Global Quality | TAX_WITHHOLD | -438.71 | $1,149 | ~$0.5M |
| August 1, 2026 | Seymour Melissa | EVP, Global Quality | OPTION_EXERCISE | -981 | — | — |
| July 20, 2026 | Sulzberger Gabrielle | — | GRANT | 4.32 | $1,147 | ~$5K |
| July 20, 2026 | Luciano Juan R | — | GRANT | 13.88 | $1,147 | ~$16K |
| July 20, 2026 | Fyrwald J Erik | — | GRANT | 8.65 | $1,147 | ~$10K |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| August 17, 2026 | Patrik Jonsson | — | — | SEC |
| August 10, 2026 | Donald Zakrowski | — | 2,000 | SEC |
| August 7, 2026 | Hakim Anat | — | 10,000 | SEC |
| July 7, 2026 | Lilly Endowment, Inc. | — | 310,000 | SEC |
| June 26, 2026 | Lilly Endowment, Inc. | — | 305,000 | SEC |
| June 10, 2026 | Yuffa Ilya | — | 2,500 | SEC |
| May 28, 2026 | Lilly Endowment, Inc. | — | 310,000 | SEC |
| May 22, 2026 | Lilly Endowment, Inc. | — | 300,000 | SEC |
| May 20, 2026 | Lilly Endowment, Inc. | — | 305,000 | SEC |
| May 6, 2026 | Lilly Endowment, Inc. | — | 300,000 | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| July 23, 2026 | — | — | — | — | SEC |